VHPI: Vet-Harts Pilot Intervention for Veterans With Coronary Heart Disease

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT01566214
Collaborator
University of Iowa (Other)
12
1
2
6
2

Study Details

Study Description

Brief Summary

The purpose of this research study is to survey patients to learn about their beliefs and behaviors related to the management of heart disease and to discuss options for making healthy lifestyle changes. From the information the investigators get from patients, the investigators hope to develop better methods for taking care of patients who have heart disease.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Motivational Interview
Phase 2

Detailed Description

Coronary heart disease (CHD) is a significant health threat among veterans. Compared to their civilian counterparts, veterans experience greater disability, reinfarction, and mortality following myocardial infarction (MI) and other acute coronary syndromes (ACS). High rates of hypertension, diabetes, and cardiac risk behaviors (e.g., smoking) and low socioeconomic status (SES) further increase veterans' CHD-related morbidity and mortality. The proposed pilot project will establish the feasibility of a telehealth nursing intervention for veterans with CHD who are recovering from MI/ACS. The Veterans Heart Attack Representations Telehealth (Vet-HART) intervention is designed to promote adaptive conceptual change in veterans' beliefs (common sense models or representations) about CHD etiology and self-management and facilitate health behavior changes (e.g., smoking cessation, medication adherence, diet management, and increased physical activity). The long-term goal of this research program is to improve veterans' quality of life (QoL) and reduce their CHD-related morbidity/mortality. The proposed project is the requisite next step in attaining that goal.

Study Design

Study Type:
Interventional
Actual Enrollment :
12 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Representational Telehealth Nursing Intervention for Veterans With CHD
Actual Study Start Date :
Apr 30, 2012
Actual Primary Completion Date :
Jun 30, 2012
Actual Study Completion Date :
Oct 31, 2012

Arms and Interventions

Arm Intervention/Treatment
Experimental: Motivational Interview

For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.

Behavioral: Motivational Interview
For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes.

No Intervention: Usual Care

For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.

Outcome Measures

Primary Outcome Measures

  1. SF-36v Physical Function Scale [Change from baseline to 3-months post hospital discharge]

    Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  2. SF-36v Role Limitations Due to Physical Health Scale [Change from baseline to 3-months post hospital discharge]

    Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  3. SF-36v Role Limitations Due to Emotional Problems Scale [Change from baseline to 3-months post hospital discharge]

    Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  4. SF-36v Energy-Fatigue Scale [Change from baseline to 3-months post hospital discharge]

    Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  5. SF-36v Emotional Well-Being Scale [Change from baseline to 3-months post hospital discharge]

    Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  6. SF-36v Social Functioning Scale [Change from baseline to 3-months post hospital discharge]

    Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  7. SF-36v Pain Scale [Change from baseline to 3-months post hospital discharge]

    Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  8. SF-36v General Health Scale [Change from baseline to 3-months post hospital discharge]

    General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  9. Seattle Angina Questionnaire Physical Limitations Scale [Change from baseline to 3-months post hospital discharge]

    Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  10. Seattle Angina Questionnaire Angina Stability Scale [Change from baseline to 3-months post hospital discharge]

    Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  11. Seattle Angina Questionnaire Angina Frequency Scale [Change from baseline to 3-months post hospital discharge]

    Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  12. Seattle Angina Questionnaire Treatment Satisfaction Scale [Change from baseline to 3-months post hospital discharge]

    Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

  13. Seattle Angina Questionnaire Disease Perception Scale [Change from baseline to 3-months post hospital discharge]

    Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Admission to an inpatient medicine unit for MI, ACS, and coronary angiography

  • Age

Exclusion Criteria:
  • Altered mental status

  • Language barriers

  • Dementia or Cognitive Impairment

  • Diagnostic Study

  • Resident in long-term care facility prior to the present admission

  • Planned discharge to a skilled or intermediate care facility or hospice

  • Lack of access to a functioning phone

Contacts and Locations

Locations

Site City State Country Postal Code
1 Iowa City VA Health Care System, Iowa City, IA Iowa City Iowa United States 52246-2208

Sponsors and Collaborators

  • VA Office of Research and Development
  • University of Iowa

Investigators

  • Principal Investigator: Mark W Vander Weg, PhD MS BA, Iowa City VA Health Care System, Iowa City, IA

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT01566214
Other Study ID Numbers:
  • PPO 09-283
  • 200910778
First Posted:
Mar 29, 2012
Last Update Posted:
Dec 24, 2018
Last Verified:
Jun 1, 2018
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Period Title: Overall Study
STARTED 6 6
COMPLETED 3 6
NOT COMPLETED 3 0

Baseline Characteristics

Arm/Group Title Motivational Interview Usual Care Total
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider. Total of all reporting groups
Overall Participants 6 6 12
Age (Years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [Years]
68.33
(11.98)
65.67
(8.64)
67.00
(10.05)
Sex: Female, Male (Count of Participants)
Female
0
0%
0
0%
0
0%
Male
6
100%
6
100%
12
100%
Race (NIH/OMB) (Count of Participants)
American Indian or Alaska Native
0
0%
0
0%
0
0%
Asian
0
0%
0
0%
0
0%
Native Hawaiian or Other Pacific Islander
0
0%
0
0%
0
0%
Black or African American
0
0%
0
0%
0
0%
White
3
50%
1
16.7%
4
33.3%
More than one race
0
0%
0
0%
0
0%
Unknown or Not Reported
3
50%
5
83.3%
8
66.7%
Region of Enrollment (participants) [Number]
United States
6
100%
6
100%
12
100%

Outcome Measures

1. Primary Outcome
Title SF-36v Physical Function Scale
Description Physical Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
Participants who completed the SF-36v at baseline, 1 month, and 3 months.
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-6.67
(7.64)
13.33
(12.52)
2. Primary Outcome
Title SF-36v Role Limitations Due to Physical Health Scale
Description Role Limitations Due to Physical Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-22.92
(35.54)
9.38
(36.39)
3. Primary Outcome
Title SF-36v Role Limitations Due to Emotional Problems Scale
Description Role Limitations Due to Emotional Problems Scale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-27.78
(25.46)
5.56
(13.61)
4. Primary Outcome
Title SF-36v Energy-Fatigue Scale
Description Energy-Fatigue Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-5.00
(42.65)
1.67
(23.49)
5. Primary Outcome
Title SF-36v Emotional Well-Being Scale
Description Emotional Well-Being Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-14.67
(37.86)
-2.00
(7.90)
6. Primary Outcome
Title SF-36v Social Functioning Scale
Description Social Functioning Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-16.67
(40.18)
-10.42
(18.40)
7. Primary Outcome
Title SF-36v Pain Scale
Description Pain Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-5.00
(13.23)
14.17
(13.10)
8. Primary Outcome
Title SF-36v General Health Scale
Description General Health Subscale from the SF-36v. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-5.00
(18.03)
4.17
(17.15)
9. Primary Outcome
Title Seattle Angina Questionnaire Physical Limitations Scale
Description Physical Limitations Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-5.93
(8.98)
3.33
(30.43)
10. Primary Outcome
Title Seattle Angina Questionnaire Angina Stability Scale
Description Angina Stability Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
Note that because 4 participants in the Usual Care group reported that they did not experience chest pain in the prior four weeks, their responses could not be included in the analysis, as the scale measures changes in the severity of chest pain. Therefore, only 2 participants in the Usual Care group contributed to the analysis.
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 2
Mean (Standard Deviation) [units on a scale]
25.00
(66.14)
-12.50
(17.68)
11. Primary Outcome
Title Seattle Angina Questionnaire Angina Frequency Scale
Description Angina Frequency Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
20.00
(43.59)
16.67
(22.51)
12. Primary Outcome
Title Seattle Angina Questionnaire Treatment Satisfaction Scale
Description Treatment Satisfaction Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
-3.92
(33.45)
7.84
(10.95)
13. Primary Outcome
Title Seattle Angina Questionnaire Disease Perception Scale
Description Disease Perception Subscale from the Seattle Angina Questionnaire. Possible scores range from 0 to 100, with higher scores indicating a better level of functioning.
Time Frame Change from baseline to 3-months post hospital discharge

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
Measure Participants 3 6
Mean (Standard Deviation) [units on a scale]
13.89
(9.62)
9.72
(17.01)

Adverse Events

Time Frame 3 Months
Adverse Event Reporting Description
Arm/Group Title Motivational Interview Usual Care
Arm/Group Description For those subjects randomly assigned to the treatment group, information from their MIHART assessment interview and medical record review will be used to select intervention scripts optimally tailored to each subjects' unique configuration of beliefs and risk factors and they will be re-contacted by telephone at 2-weeks post-hospital discharge to deliver the Vet-HART intervention. The intervention will be administered by a trained research assistant via telephone, working from a semi-structured script tailored to each subject's representations and risk factors, the call will last about 15-30 minutes. For those randomly assigned to the usual care group, they will receive standard-of-care by their regular primary care provider.
All Cause Mortality
Motivational Interview Usual Care
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/6 (0%) 0/6 (0%)
Serious Adverse Events
Motivational Interview Usual Care
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/6 (0%) 0/6 (0%)
Other (Not Including Serious) Adverse Events
Motivational Interview Usual Care
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/6 (0%) 0/6 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Mark Vander Weg
Organization Iowa City VA Health Care System
Phone 319-338-0581 ext 7717
Email mark.vanderweg@va.gov
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT01566214
Other Study ID Numbers:
  • PPO 09-283
  • 200910778
First Posted:
Mar 29, 2012
Last Update Posted:
Dec 24, 2018
Last Verified:
Jun 1, 2018